Gene · 64005
Papers2,247
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,247
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Re-Emergence of Circulation of Seasonal Influenza during COVID-19 Pandemic in Russia and Receptor Specificity of New and Dominant Clade 3C.2a1b.2a.2 A(H3N2) Viruses in 2021-2022. | Pathogens | 2022 | 36422639 | PubTator, text mining | PubMed |
| Reflections on the battle against COVID-19: The effects of emotional design factors on the communication of audio-visual art. | Front Psychol | 2022 | 36420378 | PubTator, text mining | PubMed |
| Large-scale assessment of German dairy farmers´ personality and resulting ideas for improving veterinary consultancy. | PLoS One | 2022 | 36417368 | PubTator, text mining | PubMed |
| Restriction of Influenza A Virus by SERINC5. | mBio | 2022 | 36409124 | PubTator, text mining | PubMed |
| Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses. | Immunity | 2022 | 36356572 | PubTator, text mining | PubMed |
| Sea Cucumber Saponins Derivatives Alleviate Hepatic Lipid Accumulation Effectively in Fatty Acids-Induced HepG2 Cells and Orotic Acid-Induced Rats. | Mar Drugs | 2022 | 36355027 | PubTator, text mining | PubMed |
| Respiratory illness virus infections with special emphasis on COVID-19. | Eur J Med Res | 2022 | 36348452 | PubTator, text mining | PubMed |
| Connecting multiple microenvironment proteomes uncovers the biology in head and neck cancer. | Nat Commun | 2022 | 36344512 | PubTator, text mining | PubMed |
| Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy. | Front Med (Lausanne) | 2022 | 36313997 | PubTator, text mining | PubMed |
| A cell free biomembrane platform for multimodal study of influenza virus hemagglutinin and for evaluation of entry-inhibitors against hemagglutinin. | Front Mol Biosci | 2022 | 36310596 | PubTator, text mining | PubMed |
| Chimeric Virus-like Particles Co-Displaying Hemagglutinin Stem and the C-Terminal Fragment of DnaK Confer Heterologous Influenza Protection in Mice. | Viruses | 2022 | 36298664 | PubTator, text mining | PubMed |
| In Vitro and In Vivo Biocompatible and Controlled Resveratrol Release Performances of HEMA/Alginate and HEMA/Gelatin IPN Hydrogel Scaffolds. | Polymers (Basel) | 2022 | 36298041 | PubTator, text mining | PubMed |
Serial Passaging of Seasonal H3N2 Influenza A/Singapore/G2-31.1/2014 Virus in MDCK-SIAT1 Cells and Primary Chick Embryo Cells Generates HA D457G Mutation and Other Variants in HA, NA, PB1, PB1-F2, and NS1. | Int J Mol Sci | 2022 | 36293269 | PubTator, text mining | PubMed |
| Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer. | Cells | 2022 | 36291142 | PubTator, text mining | PubMed |
| Towards Auditory Profile-Based Hearing-Aid Fittings: BEAR Rationale and Clinical Implementation. | Audiol Res | 2022 | 36285912 | PubTator, text mining | PubMed |
| How promising are HIV-1-based virus-like particles for medical applications. | Front Cell Infect Microbiol | 2022 | 36275021 | PubTator, text mining | PubMed |
| Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial. | PLoS One | 2022 | 36256646 | PubTator, text mining | PubMed |
| Membrane attachment and fusion of HIV-1, influenza A, and SARS-CoV-2: resolving the mechanisms with biophysical methods. | Biophys Rev | 2022 | 36249860 | PubTator, text mining | PubMed |
| Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus. | Front Immunol | 2022 | 36248851 | PubTator, text mining | PubMed |
| Understanding the extracellular vesicle surface for clinical molecular biology. | J Extracell Vesicles | 2022 | 36239734 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64005/papers?page=12